Zihan Yi

448 total citations
17 papers, 297 citations indexed

About

Zihan Yi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zihan Yi has authored 17 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Zihan Yi's work include Cancer, Hypoxia, and Metabolism (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Autophagy in Disease and Therapy (3 papers). Zihan Yi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Autophagy in Disease and Therapy (3 papers). Zihan Yi collaborates with scholars based in China. Zihan Yi's co-authors include Yingmin Kuang, Zhe Yang, Yuechun Zhu, Qiaoqiao Han, Lu Jiang, Lijuan Yang, Huixin Yang, Qiao Zhang, Qiao Zhang and Qiao Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Cell Death and Differentiation.

In The Last Decade

Zihan Yi

14 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zihan Yi China	10	202	141	54	33	33	17	297
Wei‐Chen Yen Taiwan	6	179 0.9×	91 0.6×	59 1.1×	46 1.4×	35 1.1×	8	308
Yanghe Zhang China	9	215 1.1×	151 1.1×	43 0.8×	21 0.6×	40 1.2×	16	385
Qingfei Meng China	8	187 0.9×	135 1.0×	29 0.5×	20 0.6×	33 1.0×	12	305
Binbin Yin China	10	165 0.8×	79 0.6×	72 1.3×	27 0.8×	50 1.5×	19	337
Honglan Zhou China	8	192 1.0×	130 0.9×	30 0.6×	18 0.5×	29 0.9×	17	316
Baiye Jin China	9	178 0.9×	85 0.6×	57 1.1×	12 0.4×	36 1.1×	21	297
Hairong Yao China	11	295 1.5×	255 1.8×	39 0.7×	7 0.2×	24 0.7×	18	427
Kasey R. Cargill United States	9	182 0.9×	52 0.4×	22 0.4×	24 0.7×	80 2.4×	13	356
Youguang Huang China	10	230 1.1×	132 0.9×	86 1.6×	9 0.3×	38 1.2×	20	353
Xiaoming Shi China	10	176 0.9×	82 0.6×	27 0.5×	27 0.8×	35 1.1×	27	302

Countries citing papers authored by Zihan Yi

Since Specialization

Citations

This map shows the geographic impact of Zihan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihan Yi more than expected).

Fields of papers citing papers by Zihan Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zihan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihan Yi. The network helps show where Zihan Yi may publish in the future.

Co-authorship network of co-authors of Zihan Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Zihan Yi. A scholar is included among the top collaborators of Zihan Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zihan Yi. Zihan Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yi, Zihan. (2025). China's New Energy Electric Vehicle Industry: Multifaceted Analysis and Future Outlook. 10(3). 59–65.

Fang, Yun, Lu Jiang, Zihan Yi, et al.. (2025). NDUFS3 promotes proliferation via glucose metabolism reprogramming inducing AMPK phosphorylating PRPS1 to increase the purine nucleotide synthesis in melanoma. Cell Death and Differentiation. 32(12). 2193–2209. 1 indexed citations

Liu, Wenjing, Xiangjie Liu, Asif Shahzad, et al.. (2025). A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase. Journal of Biological Chemistry. 301(3). 108247–108247.

Yi, Zihan, et al.. (2025). mTOR and autophagy in acute lung injury pathogenesis and therapeutic potential. Journal of Thoracic Disease. 17(4). 2679–2692.

Peng, Xiaoqi, Hongbo Zhao, Fei Hou, et al.. (2024). Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics. Clinical Cancer Research. 30(14). 3059–3072. 1 indexed citations

Yu, Feng, Lijuan Yang, Zihan Yi, et al.. (2022). NRF2-directed PRPS1 upregulation to promote the progression and metastasis of melanoma. Frontiers in Immunology. 13. 989263–989263. 6 indexed citations

Wang, Shujie, Wenjing Liu, Lifeng Wang, et al.. (2021). Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer. Journal of Cancer. 12(9). 2550–2559. 6 indexed citations

Zhang, Qiao, Shujie Wang, Qiaoqiao Han, et al.. (2021). G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression. International Journal of Medical Sciences. 19(1). 47–64. 10 indexed citations

Yang, Zhe, Lijuan Yang, Zihan Yi, et al.. (2021). Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin‐related modifier 1 modification of glucose 6‐phosphate dehydrogenase. Cancer Science. 112(10). 4075–4086. 17 indexed citations

10.

Chen, Jing, Yun Fang, Zihan Yi, et al.. (2020). LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis. BMC Cancer. 20(1). 682–682. 11 indexed citations

11.

Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2020). NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC. Cancer Cell International. 20(1). 483–483. 16 indexed citations

12.

Yi, Zihan, Yun Fang, Jing Chen, et al.. (2020). Association between diabetes mellitus and lung cancer: Meta‐analysis. European Journal of Clinical Investigation. 50(10). e13332–e13332. 28 indexed citations

13.

Zhang, Qiao, Qiaoqiao Han, Zhe Yang, et al.. (2020). G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway. International Journal of Oncology. 57(1). 197–212. 29 indexed citations

14.

Yi, Zihan, Lu Jiang, Meiling Zhou, et al.. (2019). Glutathione peroxidase 3 (GPX3) suppresses the growth of melanoma cells through reactive oxygen species (ROS)‐dependent stabilization of hypoxia‐inducible factor 1‐α and 2‐α. Journal of Cellular Biochemistry. 120(11). 19124–19136. 45 indexed citations

15.

Chen, Long, Huixin Yang, Zihan Yi, et al.. (2018). LncRNA GAS5 regulates redox balance and dysregulates the cell cycle and apoptosis in malignant melanoma cells. Journal of Cancer Research and Clinical Oncology. 145(3). 637–652. 54 indexed citations

16.

Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2017). Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma. Journal of Cancer. 8(4). 665–673. 35 indexed citations

17.

Zhang, Qiao, Zhe Yang, Qiaoqiao Han, et al.. (2017). G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3. Oncotarget. 8(65). 109043–109060. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact